FDA Inspection 1156933 — Eurofins Lancaster Laboratories, LLC
The FDA completed an inspection of Eurofins Lancaster Laboratories, LLC on October 21, 2021 in Lancaster, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 21, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Lancaster, PA (United States)